Compare TIC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TIC | BHC |
|---|---|---|
| Founded | 1991 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | N/A | N/A |
| Metric | TIC | BHC |
|---|---|---|
| Price | $9.51 | $5.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $14.63 | $8.67 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 03-27-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $1,284,070,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $41.97 | $6.81 |
| Revenue Next Year | $42.94 | $4.11 |
| P/E Ratio | ★ N/A | $6.08 |
| Revenue Growth | ★ 16.15 | 5.86 |
| 52 Week Low | $8.76 | $4.25 |
| 52 Week High | $14.94 | $8.69 |
| Indicator | TIC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 28.12 | 34.44 |
| Support Level | $8.90 | $5.62 |
| Resistance Level | $10.21 | $5.85 |
| Average True Range (ATR) | 0.46 | 0.20 |
| MACD | -0.22 | -0.05 |
| Stochastic Oscillator | 3.10 | 19.35 |
TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.